dindevan tablets 25 milligram
duncan, flockhard & co. limited - tablets - 25 milligram
dindevan tablets 50 milligram
duncan, flockhard & co. limited - tablets - 50 milligram
dindevan 100 tab
biological e. - phenindione - tab - 50mg - 100
alternating-pressure bed mattress system
endeva medical pty ltd - 63241 - alternating-pressure bed mattress system - the purpose of this mattress is to prevent pressure injuries.
compression unit, intermittent
endeva medical pty ltd - 10969 - compression unit, intermittent - external calf compression to improve venous blood flow back to heart. this is a mobile device and should be used whenever walking, sitting or bed resting during the day or after operation.
minitran- nitroglycerin patch
kindeva drug delivery l.p. - nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3) -
granisetron 3 mg/3ml
devatis limited - granisetron hydrochloride 1.12 mg/ml equivalent to granisetron 1 mg - solution for injection - 1 mg/ml - active: granisetron hydrochloride 1.12 mg/ml equivalent to granisetron 1 mg excipient: citric acid monohydrate hydrochloric acid sodium chloride sodium hydroxide water for injection - for the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy in adults for the prevention of nausea and vomiting induced by cytotoxic chemotherapy in children
ramipex
devatis limited - pramipexole hydrochloride monohydrate 0.25mg equivalent to pramipexole 0.175 mg - tablet - 0.25 mg - active: pramipexole hydrochloride monohydrate 0.25mg equivalent to pramipexole 0.175 mg excipient: colloidal silicon dioxide magnesium stearate maize starch mannitol povidone - ramipex is indicated for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.
ramipex
devatis limited - pramipexole hydrochloride monohydrate 1mg equivalent to pramipexole 0.7 mg - tablet - 1 mg - active: pramipexole hydrochloride monohydrate 1mg equivalent to pramipexole 0.7 mg excipient: colloidal silicon dioxide magnesium stearate maize starch mannitol povidone - ramipex is indicated for the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.
hydroxycarbamide
devatis limited - hydroxycarbamide 500mg; ; - capsule - 500 mg - active: hydroxycarbamide 500mg excipient: citric acid dibasic sodium phosphate erythrosine gelatin indigo carmine lactose monohydrate magnesium stearate quinoline yellow titanium dioxide - significant tumor response to hydroxycarbamide (hydroxyurea) has been demonstrated in melanoma, resistant chronic myelocytic leukemia, and recurrent metastatic or inoperable carcinoma of the ovary. hydroxycarbamide used concomitantly with irradiation therapy is intended for use in the local control of primary squamous cell (epidermoid) carcinomas of the head and neck, excluding the lip, and carcinoma of the cervix.